NEWS
News Articles
RECRO Announces David Enloe Named President and Chief Executive Officer
MALVERN, Pa., Dec. 16, 2020 (GLOBE NEWSWIRE) — Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products, today announced that David Enloe has been named President, Chief Executive Officer and a…
Read MoreCovanos Announces Appointment of Iconic Industry Leader Gil Amelio, Ph.D. to Board of Directors
ATLANTA, Dec. 16, 2020 /PRNewswire/ — Covanos, Inc., a privately-held medical technology company that is developing C-HEART, a PC-based software product that uses proprietary advances in computational fluid dynamics to rapidly and non-invasively diagnose the severity of coronary artery blockages, today announced the appointment of Gil Amelio, Ph.D. to the Covanos Board of Directors. “We are pleased to welcome Gil Amelio to the Covanos…
Read MoreFDA Approves Interhospital Patient Transport Use of VERO Biotech’s GENOSYL® Delivery System, Resulting in the Broadest Label in the Inhaled Nitric Oxide Space
The GENOSYL® DS facilitates patient treatment in interhospital and intrahospital transport, and in diverse diagnostic and imaging settings, representing the broadest FDA approved label in the industry allowing use in the Acute-care Setting including MRI, Ground, Fixed Wing and Rotary Transport. December 15, 2020 – Atlanta, GA – VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company…
Read MoreBoehringer spends €1.18bn to acquire NBE-Therapeutics
German pharma company Boehringer Ingelheim has announced that it will acquire all shares of NBE-Therapeutics for a total of €1.18bn. NBE-Therapeutics, headquartered in Switzerland, is focused on antibody-drug conjugates (ADC) for the development of targeted cancer therapies. The biotech’s immune stimulatory iADC platform creates ‘highly potent’ immune stimulatory ADCs with an anthracycline payload that are…
Read MoreFDA authorizes Pfizer’s COVID-19 vaccine
The U.S. Food and Drug Administration has granted emergency use authorization for Pfizer’s coronavirus vaccine, according to multiple news outlets. Millions of doses are expected to be shipped right away, The New York Times reported Friday night. The authorization marks a critical turning point in a pandemic that has taken nearly 300,000 lives in the United…
Read MoreGeorgia Bio Names Ashley Williams Haltom New VP of Government Affairs
Atlanta, Georgia (December 11, 2020) – Georgia Bio, the state’s public policy and business solutions organization representing Georgia’s life sciences sector, announced an addition to its team hiring Ashley Williams Haltom as the Vice President of Government Affairs. In this role, she will provide expanded leadership in developing and implementing sound public policy strategies for…
Read More